Droperidol

• 

  Subject Areas on Research

  • "Black box" warning on droperidol: report of the FDA convened expert panel. 
  • A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups. 
  • A randomized comparison of a multimodal management strategy versus combination antiemetics for the prevention of postoperative nausea and vomiting. 
  • A randomized, double-blinded comparison of ondansetron, droperidol, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy. 
  • Anaesthesia for laparoscopic cholecystectomy. 
  • Annals of Emergency Medicine Journal Club. Are 2 drugs better than 1 for acute agitation? A discussion on black box warnings, waiver of informed consent, and the ethics of enrolling impaired subjects in clinical trials: Answers to the January 2013 Journal Club questions. 
  • Comparison of different methods of administering droperidol in patient-controlled analgesia in the prevention of postoperative nausea and vomiting. 
  • Cost effectiveness ratio: an often misunderstood term. 
  • Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. 
  • Double-blind comparison of ondansetron, droperidol and saline in the prevention of postoperative nausea and vomiting. 
  • Effects of droperidol on depolarization-induced automaticity, maximum upstroke velocity (Vmax) and the kinetics of recovery of Vmax in guinea-pig ventricular myocardium. 
  • FDA "black box" warning regarding use of droperidol for postoperative nausea and vomiting: is it justified? 
  • Fentanyl-droperidol supplementation of rapid sequence induction in the presence of severe pregnancy-induced and pregnancy-aggravated hypertension. 
  • Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases. 
  • Haloperidol for postoperative nausea and vomiting: are we reinventing the wheel? 
  • Low-dose droperidol for prevention of postoperative nausea in adults. 
  • Low-dose droperidol is not devoid of serious side effects. 
  • Meta-analysis of the safety of 5-HT3 antagonists with dexamethasone or droperidol for prevention of PONV. 
  • Ondansetron versus droperidol for postoperative nausea and vomiting. 
  • Postoperative nausea and vomiting in children and adolescents undergoing radiofrequency catheter ablation: a randomized comparison of propofol- and isoflurane-based anesthetics. 
  • Pro: The Food and Drug Administration Black box warning on droperidol is not justified. 
  • Safety of patients reason for FDA black box warning on droperidol. 
  • The additive interactions between ondansetron and droperidol for preventing postoperative nausea and vomiting. 
  • The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report. 
  • The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials. 
  • The use of droperidol before and after the Food and Drug Administration black box warning: a survey of the members of the Society of Ambulatory Anesthesia. 
  • There should be a threshold dose for the FDA black-box warning on droperidol. 
  • Treating delirium among elderly patients. 
• 

  Keywords of People

  • Warner, David Samuel, Distinguished Distinguished Professor of Anesthesiology, in the School of Medicine, Neurobiology